Survival benefit in melanoma [1]

Journal of Clinical Oncology

Volumn 15, Issue 5, 1997, Pages 2172-

  Williams, M V ^a   De Takats, P ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON;

CANCER RECURRENCE; CLINICAL TRIAL; HUMAN; LETTER; MELANOMA; PRIORITY JOURNAL; QUALITY OF LIFE; SURVIVAL RATE; SURVIVAL TIME;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS; HUMANS; INTERFERON ALFA-2B; MELANOMA; SURVIVAL RATE;

EID: 0030900129     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (3)